Browse BNIP1

Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Mitochondrion. Endoplasmic reticulum membrane; Single-pass type IV membrane protein.
Domain PF03908 Sec20
Function

SNARE that may be involved in targeting and fusion of Golgi-derived retrograde transport vesicles with the ER. Required for maintenance of ER network. Implicated in the suppression of cell death. May be involved in mitochondrial autophagy.

> Gene Ontology
 
Biological Process GO:0006890 retrograde vesicle-mediated transport, Golgi to ER
GO:0006914 autophagy
GO:0007029 endoplasmic reticulum organization
GO:0016320 endoplasmic reticulum membrane fusion
GO:0044801 single-organism membrane fusion
GO:0048193 Golgi vesicle transport
GO:0048284 organelle fusion
GO:0061025 membrane fusion
GO:0090174 organelle membrane fusion
GO:0097194 execution phase of apoptosis
Molecular Function GO:0005484 SNAP receptor activity
Cellular Component GO:0005635 nuclear envelope
GO:0030176 integral component of endoplasmic reticulum membrane
GO:0031201 SNARE complex
GO:0031227 intrinsic component of endoplasmic reticulum membrane
> KEGG and Reactome Pathway
 
KEGG hsa04130 SNARE interactions in vesicular transport
Reactome R-HSA-6811434: COPI-dependent Golgi-to-ER retrograde traffic
R-HSA-8856688: Golgi-to-ER retrograde transport
R-HSA-6811442: Intra-Golgi and retrograde Golgi-to-ER traffic
R-HSA-199991: Membrane Trafficking
R-HSA-5653656: Vesicle-mediated transport
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between BNIP1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of BNIP1 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of BNIP1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)14120.1350.5
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)650.3180.82
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.0030.998
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.820.0158
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.660.469
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 471.0280.386
729033130MelanomaallAnti-PD-1 (nivolumab) 2623-0.1180.653
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 1511-0.2280.804
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 1112-0.0060.995
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 48-1.0940.391
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 28-1.190.512
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 68230-0.0870.191
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of BNIP1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 27730001
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 27590001
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21170001
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13110001
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160001
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38272.602.61
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22134.504.51
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of BNIP1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of BNIP1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by BNIP1.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of BNIP1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of BNIP1 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between BNIP1 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolBNIP1
NameBCL2/adenovirus E1B 19kDa interacting protein 1
Aliases SEC20; BCL2/adenovirus E1B 19kD-interacting protein 1; TRG-8; BCL2/adenovirus E1B 19 kDa protein-interacting ......
Chromosomal Location5q33-q34
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting BNIP1 collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.